Pharmaceutical Technology

News, views and contacts from the global Pharmaceutical industry
16 January 2018
DAILY UPDATE
Industry News

Opioid meds to no longer be labelled as suitable for children, FDA rules
The US Food and Drug Administration (FDA) has announced new labelling regulations for products containing opioids.

FDA approves Lynparza to treat inherited breast cancer
The US Food and Drug Administration (FDA) has approved the use of AstraZeneca’s Lynparza (olaparib tablets) for the treatment of certain types of breast cancer that have metastasized and those with BRCA gene mutation.

Helsinn obtains orphan designation for pracinostat to treat AML
Swiss pharmaceutical group Helsinn and US-based oncology firm MEI Pharma have obtained orphan drug designation from the European Medicines Agency (EMA) for investigational drug candidate pracinostat for the treatment of acute myeloid leukaemia (AML).

Targeted therapeutics made possible with the development of computer logic-controlled biomaterials
Researchers from the University of Washington have announced they are able to program biomaterials to target treatments to specific areas of the body using Boolean logic.

Press Releases

Gerresheimer Appoints Dr Lukas Burkhardt as New Member of the Management Board
Dr Lukas Burkhardt has been appointed to the management board of Gerresheimer effective 1 January.

Meet SHL at Drug Delivery Partnerships 2018
SHL has announced it is exhibiting at the 2018 Drug Delivery Partnerships (DDP) conference in Florida.

Pfizer CentreOne Wins 2017 CMO Leadership Award
Pfizer CentreOne, a global contract manufacturing organization embedded within Pfizer, has announced that it has been named a recipient of Life Science Leader’s 2017 CMO Leadership Awards, now in its sixth year.

ABC with DGF Performed Real Cool Chain RKN-solution from Russia
Multi-modal transportation of healthcare products from Moscow to Miami was successfully completed by ABC for DHL Global Forwarding (DGF) in accordance with Good Distribution Practice (GDP) standards of cool chain.

Gx® InnoSafe: Greater Protection Against Needlestick Injuries
Gerresheimer will present their passive integrated safety system for avoiding needlestick injuries at Pharmapack in Paris.

White Papers

Cost-Effective Way to De-Risk Biomarker Clinical Trials
This free white paper discusses the early development considerations when considering cost-effective ways to de-risk biomarker clinical trials. 

siromedes brochure
Patients with chronic pain and spasticity have a long history of pain that may extend over decades. This pain lies like an unendurable load on life and, for the person affected, this becomes an endless burden. 

Global Solutions for Pharmaceutical Packaging
BERNHARDT is specialised in the production of high barrier multilayer bags for the protection of sensitive products against oxidation, gas, moisture and UV rays.

Phase I Study: Bromodomain Inhibitor OTX015 in Patients with Acute Leukaemia
Bromodomain and extra-terminal (BET) proteins are chromatin readers that preferentially affect the transcription of genes with super-enhancers, including oncogenes.

Control of Humidity at Europe’s First -80°C Cold Store
Munters provides Odense University with Europe's first -80°C cold store for blood and tissue samples. By installing Munters ML1100 desiccant dehumidifier, the university hospital achieved improved energy efficiency on refrigeration systems and prevented the build up of ice on coils.

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Pharmaceutical Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

www.pharmaceutical-technology.com is a product of Kable.
Copyright
2018 Kable, a trading division of Kable Intelligence Limited.